Abstract

The bradykinin (BK) B 2 receptor cDNA was synthesized by rt-PCR and transfected into the Chinese hamster lung fibroblasts, CCL39. The CCL39 do not contain the mRNA for this receptor and do not bind BK. Clones of transfected cells were screened for BK receptor mRNA, binding of BK, and for [Ca 2+] i response to BK The clones showed various levels of receptor mRNA. Scatchard analysis of three clones, B6, B5 and B1, each gave a K d of approximately 1.0nM while the Bmax for each clone differed at 320, 38.7, and 5.39 fmoles per 10 6 cells respectively. The [Ca 2+] i response of the three clones to BK decreased with the receptor number/cell. Thus, levels of mRNA, BK binding and [Ca 2+] i response proved proportionally related in the transfected clones. The actions of BK and α-thrombin, which has an endogenous receptor in these cells, were assessed in clone B6. BK proved active but also distinct from thrombin. BK at 10nM and thrombin at 2units/ml both effectively increased cytosolic [Ca 2+] i. BK at l0nM stimulated PGE 2 production three fold over basal, while thrombin only marginally elevated PGE 2 levels. Alone, BK stimulated a small increase in 3H-thymidine incorporation into DNA. However, in combination with insulin, BK stimulated DNA synthesis to 76% of thrombin, a potent mitogen in these cells. These results illustrate that the BK-B 2 receptor cDNA can be stably transfected into a mammalian cell and can activate transmembrane signalling pathways.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.